Tuesday, November 24, 2009

Inflammatory Bowel Disease Home>
News>
Bowel disease drugs can increase cancer risk

Font size
- A
- A
- A
Email This

Bookmark

Save

Bowel disease drugs can increase cancer risk

(Reuters) UPDATED 2009-10-20

French researchers say that drugs for inflammatory bowel disease may increase the risk of infection-related cancers. In a study of 19,000 IBD patients, scientists found that those on thiopurines such as Imuran had a more than five-fold increased risk of developing lymphoma compared to those who had never taken a thiopurine. But researchers point out that the overall risk for developing the cancer was still low, and they suggest that the benefits of the drug may outweigh the risks for IBD sufferers. Read full story >

See all Inflammatory Bowel Disease News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyIBDCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.